Webinar
The New Cold War: Why Biotech Is National Defense
Join Alumni Ventures’ Drew Wandzilak for a compelling discussion on why biotech is emerging as a critical pillar of national defense in today’s global landscape.
From pandemic preparedness to synthetic biology and genomic security, innovation in biotech is no longer just about healthcare—it’s about geopolitical resilience. This webinar will explore how venture-backed biotech startups are shaping the future of security, stability, and strategic advantage.
You’ll gain insights into why governments and investors alike are prioritizing biotech and how this sector is becoming a new battleground for global influence. Don’t miss this opportunity to hear from AV’s investment leaders on how they’re identifying and backing the biotech companies defining the next era of national defense.
- HomeStrategic Insight: Understand how biotech innovations are integral to national and global security.
- HomeInvestment Focus: Discover why venture capital is flowing into companies like Synchron and Hyfe.
- HomePortfolio Perspective: Learn how Alumni Ventures identifies and supports transformative biotech startups.
Reserve your spot today for this timely and insightful discussion. Alumni Ventures is America’s largest venture capital firm for individual investors.
About your presenter
Drew has worked in high-growth industries as both an investor and operator, focusing on how people and technology interact within organizations. As a long-time investor with Alumni Ventures, he has worked across multiple funds and internal initiatives. He has worked on National and State level political campaigns, focusing on Small Business and Entrepreneurial policy. Drew holds a BS from Northwestern University in Education and Social Policy, specializing in Learning & Organizational Development. He also served as an Ambassador for Northwestern’s Farley Center for Entrepreneurship and Innovation and was recognized in Chicago Inno’s 25 under 25.